356 related articles for article (PubMed ID: 11283797)
1. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.
Rasmussen SA; Yang Q; Friedman JM
Am J Hum Genet; 2001 May; 68(5):1110-8. PubMed ID: 11283797
[TBL] [Abstract][Full Text] [Related]
2. Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006).
Masocco M; Kodra Y; Vichi M; Conti S; Kanieff M; Pace M; Frova L; Taruscio D
Orphanet J Rare Dis; 2011 Mar; 6():11. PubMed ID: 21439034
[TBL] [Abstract][Full Text] [Related]
3. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.
Duong TA; Sbidian E; Valeyrie-Allanore L; Vialette C; Ferkal S; Hadj-Rabia S; Glorion C; Lyonnet S; Zerah M; Kemlin I; Rodriguez D; Bastuji-Garin S; Wolkenstein P
Orphanet J Rare Dis; 2011 May; 6():18. PubMed ID: 21542925
[TBL] [Abstract][Full Text] [Related]
4. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden.
Zöller M; Rembeck B; Akesson HO; Angervall L
Acta Derm Venereol; 1995 Mar; 75(2):136-40. PubMed ID: 7604643
[TBL] [Abstract][Full Text] [Related]
5. Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989.
Evans DG; O'Hara C; Wilding A; Ingham SL; Howard E; Dawson J; Moran A; Scott-Kitching V; Holt F; Huson SM
Eur J Hum Genet; 2011 Nov; 19(11):1187-91. PubMed ID: 21694737
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
Landry JP; Schertz KL; Chiang YJ; Bhalla AD; Yi M; Keung EZ; Scally CP; Feig BW; Hunt KK; Roland CL; Guadagnolo A; Bishop AJ; Lazar AJ; Slopis JM; McCutcheon IE; Torres KE
JAMA Netw Open; 2021 Mar; 4(3):e210945. PubMed ID: 33734413
[TBL] [Abstract][Full Text] [Related]
7. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
8. Intestinal tumors in neurofibromatosis 1 with special reference to fatal gastrointestinal stromal tumors (GIST).
Ylä-Outinen H; Loponen N; Kallionpää RA; Peltonen S; Peltonen J
Mol Genet Genomic Med; 2019 Sep; 7(9):e927. PubMed ID: 31397088
[TBL] [Abstract][Full Text] [Related]
9. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
[TBL] [Abstract][Full Text] [Related]
10. Using Death Certificates to Explore Changes in Alcohol-Related Mortality in the United States, 1999 to 2017.
White AM; Castle IP; Hingson RW; Powell PA
Alcohol Clin Exp Res; 2020 Jan; 44(1):178-187. PubMed ID: 31912524
[TBL] [Abstract][Full Text] [Related]
11. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
[TBL] [Abstract][Full Text] [Related]
12. PMR study of mortality among Alabama workers and farmers.
Austin SG; Huang N; Woernle CW
Am J Ind Med; 1995 Jan; 27(1):29-36. PubMed ID: 7900733
[TBL] [Abstract][Full Text] [Related]
13. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
[TBL] [Abstract][Full Text] [Related]
14. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States.
Chorba TL; Holman RC; Clarke MJ; Evatt BL
Am J Hematol; 2001 Apr; 66(4):229-40. PubMed ID: 11279632
[TBL] [Abstract][Full Text] [Related]
15. Deaths: final data for 2000.
Miniño AM; Arias E; Kochanek KD; Murphy SL; Smith BL
Natl Vital Stat Rep; 2002 Sep; 50(15):1-119. PubMed ID: 12382630
[TBL] [Abstract][Full Text] [Related]
16. Deaths: final data for 1997.
Hoyert DL; Kochanek KD; Murphy SL
Natl Vital Stat Rep; 1999 Jun; 47(19):1-104. PubMed ID: 10410536
[TBL] [Abstract][Full Text] [Related]
17. Deaths: final data for 1996.
Peters KD; Kochanek KD; Murphy SL
Natl Vital Stat Rep; 1998 Nov; 47(9):1-100. PubMed ID: 9824931
[TBL] [Abstract][Full Text] [Related]
18. Mortality associated with polymyalgia rheumatica in the United States in the 1999-2020 period: a multiple-cause-of-death study.
Huo RX; Yang YT; Lin JY; Meng DL; Huang RJ; Huo XC; Yang Y; Huang YJ; Zhu X; Wei CC; Huang XX
Eur Rev Med Pharmacol Sci; 2024 Apr; 28(8):3144-3153. PubMed ID: 38708473
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of neurofibromatosis type 1.
Friedman JM
Am J Med Genet; 1999 Mar; 89(1):1-6. PubMed ID: 10469430
[TBL] [Abstract][Full Text] [Related]
20. Frequency of recording of diabetes on U.S. death certificates: analysis of the 1986 National Mortality Followback Survey.
Bild DE; Stevenson JM
J Clin Epidemiol; 1992 Mar; 45(3):275-81. PubMed ID: 1569424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
